DSpace Repository

Use of Stem Cells to Block the Activation of Hepatic Stellate Cells in Diseased Liver

Show simple item record

dc.contributor.author Majumder, Syamantak
dc.date.accessioned 2021-10-02T17:50:51Z
dc.date.available 2021-10-02T17:50:51Z
dc.date.issued 2014-11-12
dc.identifier.uri https://link.springer.com/chapter/10.1007/978-81-322-2110-4_17
dc.identifier.uri http://dspace.bits-pilani.ac.in:8080/xmlui/handle/123456789/2448
dc.description.abstract Liver is an important organ in vertebrates and performs major functions such as digestion, drug detoxification, and protein synthesis. Chronic liver fibrosis is a major threat to human life. The etiology of liver fibrosis includes chronic hepatitis infection, alcohol abuse, and nonalcoholic steatohepatitis. The pathophysiology of liver fibrosis shows that there is accumulation of extracellular matrix (ECM) proteins including collagen, proteoglycan, and adhesive glycoproteins. Activated hepatic stellate cells (HSCs) are the major collagen-producing cells in the liver. The present in vitro study demonstrates that bipotential murine oval liver (BMOL) stem cells secrete soluble factors, which are capable of inducing apoptosis in activated HSCs and inhibit the formation of collagen. Further, the study can be extended to identify the soluble factors capable of attenuating activated HSCs and opens a new research direction to control liver fibrosis. en_US
dc.language.iso en en_US
dc.publisher Springer en_US
dc.subject Biology en_US
dc.subject Conditioned Medium en_US
dc.subject Liver Fibrosis en_US
dc.subject Hepatic Stellate Cell en_US
dc.title Use of Stem Cells to Block the Activation of Hepatic Stellate Cells in Diseased Liver en_US
dc.type Book chapter en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account